Effects of Clustering Care on the Physiological Stability of Preterm Infants.

NCT ID: NCT03490721

Last Updated: 2020-01-18

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

10 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-09-12

Study Completion Date

2019-05-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This crossover design experimental study aims to compare the physiological stability of premature newborns during and after a cluster of care compared to a period when they receive standard non clustered care at the neonatal unit.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The cluster care will take place at the time of feeding of the premature infants. The intervention will start with a calm period of 20 minutes before the start of care (no manipulations will be allowed), the baby will then received the cluster care for 20 minutes and a quiet period of 30 minutes will follow after the cluster care.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Premature Baby 26 to 32 Weeks

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Intervention

Clustering care for 20 minutes.

Group Type EXPERIMENTAL

Clustering care

Intervention Type OTHER

During 20 minutes, preterm infants will receive a cluster care with 2 minutes of hand containment.

Control

Standard care non clustered.

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Clustering care

During 20 minutes, preterm infants will receive a cluster care with 2 minutes of hand containment.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* between 26 to 31 6/7 weeks of gestation at birth
* more than 72 hours of life,
* receive a respiratory aid such as endotracheal tube, NIPPV (non invasive positive pressures ventilation), CPAP (continuous positive airway pressure) or nasal prongs with oxygen,
* are fed intravenously (IV) or by central venous catheter (CVC),
* one of the parents speaks and reads English or French,
* one of the parents is at least 18 years old to sign the consent.

Exclusion Criteria

* severely ill (necrotizing enterocolitis, septicemia),
* under respiratory assistance or on a high frequency mode,
* having a congenital or cardiac abnormality,
* requiring surgery,
* sedatives or opioids,
* diagnosed with grade II, III or IV intraventricular hemorrhage and / or hydrocephalus,
* have a device for invasive blood pressure,
* having an oxygen requirement of more than 30% to maintain oxygen saturation within the limits indicated by the NICU (neonatal intensive care unit).
* one of the parents is at least 18 years old to sign the consent.
Minimum Eligible Age

26 Weeks

Maximum Eligible Age

32 Weeks

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Université de Montréal

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Abril Nicole Fernandez Oviedo

Principal investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Marilyn Aita, PhD

Role: STUDY_DIRECTOR

Université de Montréal

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Jewish General Hospital

Montreal, Quebec, Canada

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Canada

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Etude_maitrise_2018

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.